Ai E, Gardner T W
Department of Ophthalmology, California Pacific Medical Center, San Francisco 94115.
Arch Ophthalmol. 1993 Mar;111(3):331-2. doi: 10.1001/archopht.1993.01090030049037.
A 1987 survey of 365 members of the Retina and Vitreous societies revealed that use of long-acting intraocular gases was both widespread and frequent. However, despite the expanded use of intravitreal gases and the stated intention of the Food and Drug Administration to approve premarket applications for use of sulfur hexafluoride and perfluoropropane, there are still limitations in the ready availability of these substances. Therefore, we conducted another survey to determine current patterns of intraocular gas use. The results indicate that more surgeons are using long-acting gases. The data also demonstrate the selective use of pneumatic retinopexy with geographic pockets of increased retinopexy use in California and Florida. Finally, 100% of respondents now indicate that they consider the use of sulfur hexafluoride and perfluoropropane to be a standard of care.
1987年对视网膜和玻璃体协会365名成员进行的一项调查显示，长效眼内气体的使用既广泛又频繁。然而，尽管玻璃体内气体的使用有所增加，且美国食品药品监督管理局表示有意批准六氟化硫和全氟丙烷的上市前应用，但这些物质的现成可得性仍存在局限性。因此，我们进行了另一项调查，以确定眼内气体的当前使用模式。结果表明，越来越多的外科医生在使用长效气体。数据还显示了在加利福尼亚州和佛罗里达州，气动视网膜固定术的使用具有选择性，视网膜固定术的使用在这些地区有所增加。最后，100%的受访者现在表示，他们认为使用六氟化硫和全氟丙烷是一种护理标准。
